Lower sales costs boost ATL profits

Article

Officials of ultrasound vendor Advanced Technology Laboratoriescredit product cost reductions and the end of restructuring costsrelated to its acquisition of Interspec for a profitable firstquarter (end-March). Net income for the quarter rose to $3

Officials of ultrasound vendor Advanced Technology Laboratoriescredit product cost reductions and the end of restructuring costsrelated to its acquisition of Interspec for a profitable firstquarter (end-March).

Net income for the quarter rose to $3 million compared witha $274,000 loss in the same period of 1995. Sales of $94.8 millionwere up slightly compared with $94.4 million in last year's firstquarter, but the company reduced product sales costs and no longerfaced the restructuring charges that took the blame for most ofits first-quarter 1995 losses.

Chairman and chief executive Dennis Fill expects further improvementin the company's results due to its new sales effort in Japanand from a recent Food and Drug Administration ruling that willallow ATL to market the use of its Ultramark 9 HDI scanner forspecialized breast imaging applications.

Hitachi, ATL's distribution partner in Japan, is moving forwardwith its marketing campaign after gaining all necessary Japanesegovernment approvals in that country for the HDI 3000 premiumscanner, according to Fill. On April 12, ATL announced that theFDA had approved its premarket approval application to use Ultramark9 HDI as an adjunct to mammography to differentiate suspiciousmasses (SCAN 4/24/96).

Officials at the Bothell, WA, company also expect to beginshipments this month of HDI 3000 scanners equipped with the vendor'snew 3-D vascular visualization features.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.